NVAX (STOCKS)
Novavax Inc
$8.129500
+0.169500 (+2.13%)
Prev close: $7.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John C.s Jacobs
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,440.54M
- Employees
- 1,992
- P/E (TTM)
- -5.34
- P/B (TTM)
- -7.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
2
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.32 | $-0.39 | +0.0733 | +18.64% |
|
Mar 2026 (Q1)
|
$-0.06 | $-0.23 | +0.1749 | +74.46% |
|
Dec 2025 (Q4)
|
$0.11 | $-0.50 | +0.6067 | +122.15% |
|
Sep 2025 (Q3)
|
$-1.25 | $-1.21 | -0.0400 | -3.31% |
Financial Statements
| Revenues | $413.80M |
| Benefits Costs and Expenses | $659.11M |
| Cost Of Revenue | $88.54M |
| Costs And Expenses | $647.92M |
| Gross Profit | $325.26M |
| Operating Expenses | $559.38M |
| Selling, General, and Administrative Expenses | $121.22M |
| Depreciation and Amortization | $17.83M |
| Research and Development | $340.32M |
| Operating Income/Loss | -$234.12M |
| Income/Loss From Continuing Operations After Tax | -$247.73M |
| Income/Loss From Continuing Operations Before Tax | -$245.32M |
| Income Tax Expense/Benefit | $2.42M |
| Net Income/Loss | -$247.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$247.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$247.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.52 |
| Diluted Earnings Per Share | -$1.58 |
| Basic Average Shares | 326,462,000 |
| Diluted Average Shares | 331,190,000 |
| Assets | $955.58M |
| Current Assets | $771.10M |
| Inventory | $10.01M |
| Other Current Assets | $761.09M |
| Noncurrent Assets | $184.48M |
| Fixed Assets | $38.13M |
| Other Non-current Assets | $146.34M |
| Liabilities | $1.15B |
| Current Liabilities | $330.57M |
| Accounts Payable | $22.94M |
| Other Current Liabilities | $307.64M |
| Noncurrent Liabilities | $815.71M |
| Long-term Debt | $291.49M |
| Other Non-current Liabilities | $524.22M |
| Equity | -$190.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$190.71M |
| Liabilities And Equity | $955.58M |
| Net Cash Flow From Operating Activities | -$36.90M |
| Net Cash Flow From Operating Activities, Continuing | -$36.90M |
| Net Cash Flow From Investing Activities | -$109.51M |
| Net Cash Flow From Investing Activities, Continuing | -$109.51M |
| Net Cash Flow From Financing Activities | $74.71M |
| Net Cash Flow From Financing Activities, Continuing | $74.71M |
| Exchange Gains/Losses | -$1.25M |
| Net Cash Flow | -$72.94M |
| Net Cash Flow, Continuing | -$71.70M |
| Comprehensive Income/Loss | -$254.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$254.72M |
| Other Comprehensive Income/Loss | -$254.72M |
| Other Comprehensive Income/Loss Attributable To Parent | -$6.99M |